Insights from the conduct of a device trial in older persons: low magnitude mechanical stimulation for musculoskeletal health

Abstract

Background Osteoporosis is a common complication of aging. Alternatives to pharmacologic treatment are needed for older adults. Nonpharmacologic treatment with low magnitude, high frequency mechanical stimulation has been shown to prevent bone loss in animal and human studies.

Methods The VIBES (Vibration to Improve Bone Density in Elderly Subjects) study is a randomized, double-blind, sham-controlled trial of the efficacy of low magnitude, high frequency mechanical stimulation in 200 men and women aged 60 years and older with bone mineral density T-scores by dual X-ray absorptiometry between —1 and —2.5 at entry. Participants are healthy, cognitively intact residents of independent living communities in the Boston area who receive free calcium and Vitamin D supplements. They are randomly assigned to active or sham treatment and stand on their assigned platform once daily for 10 min. All platforms have adherence data collection software downloadable to a laptop computer. Adverse events are closely monitored. 174 participants were randomized and will be followed for 2 years. Almost all active subjects have attained 1 year of follow-up. Bone mineral density is measured by both dual X-ray absorptiometry and quantitative computed tomography at baseline and annually. The main analysis will compare mean changes from baseline in volumetric bone density by quantitative computed tomography in active and sham groups. Adherence and treatment effect magnitude will also be evaluated. Secondary analyses will compare changes in two biochemical markers of bone turnover as well as longitudinal comparisons of muscle and balance endpoints.

Results The VIBES trial has completed its first year of data collection and encountered multiple challenges leading to valuable lessons learned about the areas of recruitment from independent living communities, deployment of multiuser mechanical devices using radio frequency identification cards and electronic adherence monitoring, organization of transportation for imaging at a central site, and the expansion of study aims to include additional musculoskeletal outcomes.

Conclusions These lessons will guide future investigations in studies of individuals of advanced age. Clinical Trials 2010; 7: 354—367. http://ctj.sagepub.com

Get full access to this article

View all access options for this article.

References

NIH (ed). Osteoporosis prevention, diagnosis and therapy. In: NIH Consensus Development Conference, Natcher Auditorium, NIH, Washington, DC, 2000.

Rossouw JE , Anderson GL , Prentice RL , et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33.

Siris ES , Harris ST , Rosen CJ , et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: Relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc 2006; 81: 1013-22.

Warden SJ , Fuchs RK , Castillo AB , et al. Exercise when young provides lifelong benefits to bone structure and strength. J Bone Miner Res 2007; 22: 251-9.

Rosenberg IH Sarcopenia: Origins and clinical relevance . J Nutr 1997; 127: 990S-91S.

Burr DB , Forwood MR , Fyhrie DP , et al. Bone micro-damage and skeletal fragility in osteoporotic and stress fractures. J Bone Miner Res 1997; 12: 6-15.

Frost HM Skeletal structural adaptations to mechanical usage (SATMU): 1. Redefining Wolff’s law: The bone modeling problem. Anat Rec 1990; 226: 403-13.

Gilsanz V. , Wren TA , Sanchez M. , et al. Low-level, high-frequency mechanical signals enhance musculoskeletal development of young women with low BMD. J Bone Miner Res 2006; 21: 1464-74.

Jenkins KR , Pienta AM , Horgas AL Activity and health-related quality of life in continuing care retirement communities. Res Aging 2002; 24: 124-30.

10.

Wendel VI , Durso SC , Remsburg RE Studying coronary artery disease in the retirement community. Nurse Pract 2001; 26: 48-55.

11.

Blessed G. , Tomlinson BE , Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114: 797-811.

12.

Bouxsein ML Technology insight: Noninvasive assessment of bone strength in osteoporosis. Nat Clin Pract Rheumatol 2008; 4: 310-18.

13.

Black DM , Greenspan SL , Ensrud KE , et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 2003; 349: 1207-15.

14.

McClung MR , San Martin J. , Miller PD , et al. Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. Arch Intern Med 2005 ; 165: 1762-8.

15.

Rubin C. , Turner AS , Mallinckrodt C. , et al. Mechanical strain, induced noninvasively in the high-frequency domain, is anabolic to cancellous bone, but not cortical bone. Bone 2002; 30: 445-52.

16.

Lang T. , LeBlanc A. , Evans H. , et al. Cortical and trabecular bone mineral loss from the spine and hip in long-duration spaceflight. J Bone Miner Res 2004; 19: 1006-12.

17.

Lang TF , Leblanc AD , Evans HJ , et al. Adaptation of the proximal femur to skeletal reloading after long-duration spaceflight. J Bone Miner Res 2006; 21: 1224-30.

18.

Marshall LM , Zmuda JM , Chan BK , et al. Race and ethnic variation in proximal femur structure and BMD among older men. J Bone Miner Res 2008; 23: 121-30.

19.

Li W. , Sode M. , Saeed I. , et al. Automated registration of hip and spine for longitudinal QCT studies: Integration with 3D densitometric and structural analysis. Bone 2006; 38: 273-9.

20.

Canalis E. , Giustina A. , Bilezikian JP Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 2007; 357: 905-16.

21.

Bilezikian JP Combination anabolic and antiresorptive therapy for osteoporosis: Opening the anabolic window. Curr Osteoporos Rep 2008; 6: 24-30.

22.

Leveille SG , Kiel DP , Jones RN , et al. The MOBILIZE Boston Study: Design and methods of a prospective cohort study of novel risk factors for falls in an older population. BMC Geriatr 2008; 8: 16-23.

23.

Ward K. , Alsop C. , Caulton J. , et al. Low magnitude mechanical loading is osteogenic in children with disabling conditions. J Bone Miner Res 2004 ; 19: 360-9.

24.

Hannan MT , Cheng DM , Green E. , et al. Establishing the compliance in elderly women for use of a low level mechanical stress device in a clinical osteoporosis study. Osteoporos Int 2004; 15: 918-26.

25.

Goel VK , Park H. , Kong W. Investigation of vibration characteristics of the ligamentous lumbar spine using the finite element approach. J Biomech Eng 1994; 116: 377-83.

26.

Magnusson ML , Pope MH , Wilder DG , et al. Are occupational drivers at an increased risk for developing musculoskeletal disorders? Spine 1996; 21: 710-17.

27.

Dandanell R. , Engstrom K. Vibration from riveting tools in the frequency range 6Hz-10MHz and Raynaud’s phenomenon. Scand J Work Environ Health 1986 ; 12: 338-42.

28.

Bernard B. , Nelson N. , Estill CF , et al. The NIOSH review of hand-arm vibration syndrome: Vigilance is crucial. National Institute of Occupational Safety and Health. J Occup Environ Med 1998; 40: 780-5.

29.

Collins MW , Lovell MR , Iverson GL , et al. Cumulative effects of concussion in high school athletes. Neurosurgery 2002; 51: 1175-9, discussion 80-81.

30.

Bongers PM , Boshuizen HC , Hulshof CT , et al. Long-term sickness absence due to back disorders in crane operators exposed to whole-body vibration. Int Arch Occup Environ Health 1988; 61: 59-64.

31.

Griffin MJ Predicting the hazards of whole-body vibration- considerations of a standard . Ind Health 1998; 36: 83-91.

32.

Judex S. , Boyd S. , Qin YX , et al. Adaptations of trabecular bone to low magnitude vibrations result in more uniform stress and strain under load. Ann Biomed Eng 2003; 31: 12-20.

33.

Rubin CT , Lanyon LE Limb mechanics as a function of speed and gait: A study of functional strains in the radius and tibia of horse and dog. J Exp Biol 1982; 101: 187-211.

34.

ISO. Evaluation of Human Exposure to Whole-Body Vibration. International Standards Organization, Geneva, 1985 (Report No.: ISO 2631/1).

35.

O’Brien R. , Muller K. Applied Analysis of Variance in Behavior Sciences . Marcel Dekker, New York, 1993.

36.

Moser B. , Stevens G. , Watts C. The two-sample test versus Satterthwaite’s approximate F test . Commun Statist Theory Meth 1989; 18: 3963-75.

37.

Liang KY , Zeger SL Longitudinal data analysis using generalized linear models. Biometika 1986; 73: 13-22.

38.

Laird NM , Ware JH Random-effects models for longitudinal data. Biometrics 1982; 38: 963-74.

39.

Hu F. , Goldberg J. , Hedeker D. , et al. Comparison of population-averaged and subject-specific approaches for analyzing repeated binary outcomes. Am J Epidemiol 1998; 147: 694-703.

40.

Park T. A comparision of the generalized estimating equation approach with the maximum likelihood approach for repeated measurements. Stat Med 1993; 12: 1723-32.

41.

Lan K. , DeMets D. Discrete sequential boundaries for clinical trials. Biometrika 1983; 70: 659-63.

42.

Pampallona S. , Tsiatis A. , Kim K. Spending functions for type I and type II error probabilities of group sequential trials. Technical Report, Boston, Harvard School of Public Health, MA, 1995.

43.

Pampallona S. , Tsiatis A. , Kim K. Interim monitoring of group sequential trials using spending functions for tpe I and type II error probabilities. Drug Inf J 2001; 35: 1113-21.

44.

Pampallona S. , Tsiatis A. , Kim K. Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hyposthesis. J Stat Plan Inf 1994 ; 42: 19-35.

45.

O’ Brien PC , Fleming TR A multiple testing procedure for clinical trials. Biometrics 1979; 35: 549-56.

46.

Cytel Software Corporation. East (5edn). Cytel Software Corporation, Cambridge, MA, 2003.

47.

Statistical Solutions. nQuery (5edn). Statistical Solutions , Saugus, MA, 2002.

48.

Black DM , Bilezikian JP , Ensrud KE , et al. One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis. N Engl J Med 2005 ; 353: 555-65.

49.

Genant HK , Lang T. , Fuerst T. , et al. Treatment with raloxifene for 2 years increases vertebral bone mineral density as measured by volumetric quantitative computed tomography . Bone 2004; 35: 1164-8.